Isolation from a Nonclinical Sample of Leclercia adecarboxylata Producing a VIM-1 Metallo-β-Lactamase-Reference-Cited by-同舟云学术

Isolation from a Nonclinical Sample of Leclercia adecarboxylata Producing a VIM-1 Metallo-β-Lactamase

Published:2013-03-25 Issue:6 Volume:57 Page:2896-2897
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob. Agents Chemother.

Author:

Papagiannitsis Costas C.,Študentová Vendula,Hrabák Jaroslav,Kubele Jan,Jindrák Vlastimil,Žemličková Helena

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference14 articles.

1. Isolation from blood culture of a Leclercia adecarboxylata strain producing an SHV-12 extended-spectrum beta-lactamase;Mazzariol;J. Clin. Microbiol,2003

3. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution;European Committee on Antimicrobial Susceptibility Testing;Clin. Microbiol. Infect,2003

4. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI-TOF mass spectrometry;Hrabak;J. Clin. Microbiol,2012

5. Identification and screening of carbapenemase producing Enterobacteriaceae;European Network on Carbapenemases;Clin. Microbiol. Infect,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of the mobile colistin resistance gene mcr-1 in a Leclercia adecarboxylata strain isolated from wastewater in Seoul;Journal of Global Antimicrobial Resistance;2024-12

2. First clinical case of VIM-1-producing Leclercia adecarboxylata: A case report and literature review;Medicine in Microecology;2023-03

3. First case of VIM-1-producing Leclercia adecarboxylata in Oman: A case report and literature review.;2022-08-29

4. First case of VIM-1-producing Leclercia adecarboxylata in Oman: A case report and literature review;2022-08-24

5. Molecular investigation of an outbreak associated with total parenteral nutrition contaminated with NDM-producing Leclercia adecarboxylata;BMC Infectious Diseases;2021-02-28